Archives April 2026

Business Wire India

Inventurus Knowledge Solutions, Inc. (“IKS”), the U.S. subsidiary of Inventurus Knowledge Solutions Limited (NSE: IKS) (“IKS Health”), a global leader in care enablement solutions, today announced it has entered into a definitive agreement to acquire TruBridge, Inc. (NASDAQ: TBRG) (“TruBridge”), a prominent provider of healthcare technology solutions for rural and community hospitals. This proposed strategic acquisition underscores a commitment to broaden access to high-quality care and support the clinicians and hospitals that serve communities across the United States.

Today, nearly one in five Americans face challenges accessing care. By bringing together IKS Health’s comprehensive care enablement capabilities that serve a range of healthcare organizations with TruBridge’s deep expertise in supporting rural and community hospitals through revenue cycle management and electronic health record (EHR) solutions, the combined healthcare technology company is expected to strengthen local healthcare systems, and enable patients to receive essential care closer to home while also enhancing care delivery across the ambulatory and acute care continuum.

Post closing, the combined company will deliver continuous improvement and connected workflows to the core of rural healthcare and to medical groups overall, combining agentic artificial intelligence (AI) with human-in-the-loop expertise to proactively address complex operational challenges. As the platform incorporates a broader range of clinical and financial data, it is designed to become increasingly intelligent and efficient. This growing intelligence, reinforced by human insight, is anticipated to ensure community hospitals and medical groups have the financial resilience and advanced support needed to focus on the health of their patients.

“By welcoming TruBridge, IKS Health is extending its proven, clinician-first experience to the vital rural and community hospital market,” said Sachin K. Gupta, Founder and Global CEO of IKS Health. “This new entity supports our long-term vision of building a comprehensive care ecosystem for all types of healthcare organizations. By pairing TruBridge’s essential system of record with our AI-driven system of action, we are moving beyond simply recording data to actively solving the complex operational challenges facing providers today. The combined entity will work toward ensuring community care teams have the same access to advanced technology and financial resilience, enabling them to deliver exceptional care close to home.”

Together, the organization will bring modern revenue cycle management, predictive analytics, and advanced EHR capabilities to support more than 2,000 healthcare organizations and over 150,000 clinicians with a broad portfolio of AI-driven and human-led solutions designed to improve clinical, operational, and financial excellence.

“I am excited for TruBridge and IKS Health to combine forces and expand the focus on strengthening rural and community healthcare,” said Chris Fowler, President and CEO of TruBridge. “IKS Health shares our passion to improve provider experiences and financial results, ultimately leading to healthier lives and positive patient outcomes. It’s rewarding to know that our employees will have more ways and opportunities to deliver exceptional value to our customers and their patients.”

“Under the terms of the agreement, TruBridge shareholders will receive $26.25 in cash for each share of common stock. The acquisition has been approved by the Boards of Directors of IKS Health, IKS, and TruBridge, and is expected to close during the third calendar quarter of 2026, subject to the satisfaction of customary closing conditions, including the requisite shareholder approvals and the Hart-Scott-Rodino (HSR) notification and waiting period. In connection with the transaction, TruBridge has entered into voting and support agreements with TruBridge’s largest shareholders, Pinetree Capital Ltd., L6 Holdings Inc. and Ocho Investments, LLC, who have agreed—subject to the terms of the agreements—to, among other things, vote the shares they control, representing in total approximately 27% of TruBridge’s outstanding shares of common stock, in favor of the transaction.”

IKS will finance the acquisition primarily through the incurrence of new indebtedness, including a term loan underwritten by Citibank, JPMorganChase, and Deutsche Bank, which is subject to satisfaction of customary conditions (including approval of the shareholders of IKS Health).

Advisors

Solomon Partners Securities, LLC is acting as the exclusive financial advisor to TruBridge, and Sullivan & Cromwell LLP, and Maynard Nexsen PC, and Cyril Amarchand Mangaldas are acting as legal counsel. J.P. Morgan Securities LLC and Citigroup Global Markets India Private Limited are acting as financial advisors to IKS Health, and Katten Muchin Rosenman LLP and Shardul Amarchand Mangaldas & Co. are acting as legal counsel.

Business Wire India

Philip Morris International¹ (NYSE: PM) today announced an expanded partnership with Ducati Corse for the 2026 season and beyond. This next chapter introduces a major development: the ZYN brand of nicotine pouches—the number one nicotine pouch brand globally²—will feature on Ducati Corse MotoGP liveries at select races throughout the seasons.

 

Just as Ducati pushes the limits of performance, ZYN represents PMI’s commitment to delivering innovation, offering a product that delivers exceptional quality while being thoughtfully designed. This partnership allows ZYN to connect with adult consumers in a space they’re passionate about—and to do so in a way that’s authentic, respectful, and dynamic.

 

 

Philip Morris International’s relationship with Ducati Corse began in 2003—the year Ducati arrived in MotoGP—ushering in a bold new era of ambition. Since then, the collaboration has evolved alongside both organizations’ transformations. Today, as PMI advances its efforts to make cigarettes obsolete and Ducati continues to lead high-performance motorcycle racing, the partnership enters a new chapter—defined by innovation, unforgettable experiences, and a shared belief in the power of progress to shape a better future.

 

 

“Across its racing history, Ducati has repeatedly challenged convention—developing groundbreaking concepts and reshaping modern MotoGP with innovations that have set new performance standards for the sport. This bold new chapter reinforces a spirit of relentless innovation and unforgettable experiences that has defined the partnership for decades,” said Nikolaus Ricketts, President, Oral Products at Philip Morris International. “As we deepen our partnership with Ducati Corse, we’re working to accelerate the move beyond cigarettes—and we want adult nicotine consumers, including ZYN consumers, to share in the excitement at every turn.”

 

 

“Our relationship with Philip Morris International began in parallel with our MotoGP project. PMI was—and still is—a key partner that has continuously evolved alongside our sporting and technological ambitions. This new chapter reflects a shared vision built on innovation, performance, and progress,” said Mauro Grassilli, Sporting Director at Ducati Corse. “Ducati Corse has always chosen partners with vision and a strong sense of responsibility, and we are proud to continue a collaboration that supports our commitment to excellence on the track and beyond.”

 

 

Responsible Marketing

 

 

Philip Morris International’s marketing and sales policies and practices reflect our commitment to market all our products responsibly. This means increasing adult consumers’ awareness and understanding of our smoke-free product portfolio while guarding against access by unintended audiences. MotoGP—with its overwhelmingly adult audience—is a global platform where we engage adult consumers worldwide with a message of choice and innovative alternatives to cigarettes.

 

 

About ZYN

 

 

ZYN nicotine pouches—the number one nicotine pouch brand globally³. In the U.S., they were the first nicotine pouches authorized as appropriate to protect public health by the U.S. Food and Drug Administration. ZYN nicotine pouches are not risk-free and contain nicotine, which is addictive. They are only for legal-aged adult consumers of nicotine products and are not alternatives to quitting tobacco and nicotine altogether.

 

 

Philip Morris International is the global smoke-free champion—with the number one heated-tobacco product globally, ZYN as the number one nicotine pouch brand globally, and our offerings in the e-vapor category as important complements. The company now provides its broadest range of smoke-free products that deliver different usage, taste, price, and technology options to maximize the number of adult smokers who can find a better alternative that will help them switch away from smoking.

 

 

Philip Morris International: A Global Smoke-Free Champion

 

 

Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch and e-vapor products. Our smoke-free products are available for sale in over 105 markets, and as of December 31, 2025, PMI estimates they were used by over 43 million legal-age consumers around the world, many of whom have moved away from cigarettes or significantly reduced their consumption. The smoke-free business accounted for 43% of PMI’s first-quarter 2026 total net revenues. Since 2008, PMI has invested over $16 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. Following a robust science-based review, the U.S. Food and Drug Administration has authorized the marketing of Swedish Match’s General snus and ZYN nicotine pouches and versions of PMI’s IQOS devices and consumables – the first-ever such authorizations in their respective categories. Versions of IQOS devices and consumablesand General snus also obtained the first-ever Modified Risk Tobacco Product authorizations from the FDA. With a strong foundation and significant expertise in life sciences, PMI has a long-term ambition to expand into wellness areas. References to “PMI”, “we”, “our” and “us” mean Philip Morris International Inc., and its subsidiaries. For more information, please visit www.pmi.com and www.pmiscience.com.

 

 

¹ References to “PMI”, “we”, “our” and “us” mean Philip Morris International Inc., and its subsidiaries. For more information, please visit www.pmi.com and www.pmiscience.com.
² Based on estimated PMI share of nicotine pouch category IMS on a pouch basis in markets where present in full year 2025.
³ Based on estimated PMI share of nicotine pouch category IMS on a pouch basis in markets where present in full year 2025.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260423020840/en/

 

Business Wire India

 

• Mangaciclanol, if approved, could transform contrast-enhanced MR imaging by offering an alternative to – or even replacing – gadolinium-based MRI agents
• A manganese-based MRI contrast agent could address concerns with gadolinium-based contrast agents around retention in the body, security of supply, and the environment, with mangaciclanol’s clinical development under FDA Fast Track designation
• The program demonstrates GE HealthCare’s commitment to advancing novel imaging agents to address unmet patient needs

 

GE HealthCare (Nasdaq: GEHC) today announced the first patient has been dosed in the international, multi-center Phase 2/3 LUMINA clinical trial of its manganese-based magnetic resonance imaging (MRI) contrast agent, mangaciclanol, at Mayo Clinic in Rochester, Minnesota. Mangaciclanol, if approved, could offer an alternative to – or even replace – gadolinium-based MRI contrast agents, the current standard of care. The investigational agent has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for use in adults and pediatric patients aged 2 years and older with MRI to detect and visualize lesions with abnormal vascularity in the central nervous system and the body. FDA Fast Track designation expedites the review of new therapeutics and medical imaging agents that have the potential to address significant unmet patient needs.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260423262096/en/

 

 

 

MRI contrast agents enhance the visualization of abnormal structures or lesions during imaging procedures and help clinicians better distinguish between healthy and diseased tissue. Mangaciclanol is intended for general-purpose MR imaging and demonstrates comparable relaxivity (the ability to enhance signal intensity) to market-leading gadolinium-based agent, gadobutrol, with early clinical images suggesting similar diagnostic capability. Unlike gadolinium, which is a rare-earth metal, manganese is present in our food, and is an endogenous element, naturally occurring and autoregulated in the body. The macrocyclic ‘cage-like’ structure of mangaciclanol lessens the possibility of retention.

 

Approximately one-third of global MRI procedures require a contrast agent for effective diagnosis,¹ with around 65 million gadolinium contrast enhanced procedures globally each year.² As a rare-earth element, gadolinium supply is largely dependent on mining and processing infrastructure in China. Manganese, however, is abundantly available from multiple countries, including South Africa, Australia and Gabon, reducing the risk of supply challenges impacting patient care. Furthermore, as manganese is naturally found in water sources, mangaciclanol could also reduce environmental concerns associated with post-patient excreted contrast media in groundwater.

 

 

Dr Jit Saini, Chief Medical Officer, Pharmacutical Diagnostics, GE HealthCare, said, “Existing gadolinium-based contrast agents carry safety language associated with gadolinium retention. In comparison, mangaciclanol could offer an alternative for broad patient groups, including vulnerable patients and those requiring multiple scans, while still offering similar diagnostic performance. The FDA Fast Track designation recognizes the potential significance of mangaciclanol and aligns with our focus on advancing its development for patients.”

 

 

“As demand for diagnostic imaging continues to rise, we continue to advance our imaging agent pipeline to better meet the needs of patients,” said Peter Arduini, President and CEO, GE HealthCare. “This clinical milestone builds on GE HealthCare’s leadership in contrast media, as mangaciclanol has the potential to transform the MR imaging market and strengthen the resiliency of its supply chain.”

 

 

Phase 1 results for mangaciclanol showed the investigational agent was well tolerated in a first in human trial with no serious adverse events, no dose limiting toxicities, nor clinically relevant findings reported.

 

 

GE HealthCare’s Pharmaceutical Diagnostics unit is a global leader in imaging agents used to support 140 million patient procedures per year globally, equivalent to four procedures every second. For more than 40 years, GE HealthCare contrast media has been routinely used across MRI, X-ray/CT and ultrasound to enhance clinical images and support diagnosis.

 

 

Mangaciclanol is in clinical development and currently not approved for use.

 

 

About GE HealthCare Technologies Inc.

 

 

GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics segments to help clinicians deliver more personalized, precise patient care. We are a $20.6 billion business with approximately 54,000 colleagues working to create a world where healthcare has no limits.

 

 

GE HealthCare is proud to be among 2026 Fortune World’s Most Admired Companies™.

 

 

Follow us on LinkedIn, Facebook, Instagram, or visit our website for our latest news and perspectives.

 

 

¹ Contrast Agents of Magnetic Resonance Imaging and Future Perspective.Nanomaterials. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC10343825/[europepmc.org]
²Recent Developments and Future Perspectives in Magnetic Resonance Imaging and Computed Tomography Contrast Media.Frontiers in Radiology. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC12871431/

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260423262096/en/

 

Business Wire India

NielsenIQ (NYSE: NIQ) today announced the launch of NIQ Commerce Lab, where the company is building the technology infrastructure for AI-driven commerce. The Lab will develop the data platforms, APIs, and measurement systems that power how products are discovered, evaluated, and purchased in AI-mediated environments.

 

This includes what the industry often refers to as agentic commerce, but extends across quick commerce, social commerce, and other emerging channels—where AI is becoming the common layer shaping how consumers navigate choices and how decisions are made in real time.

 

 

AI systems are rapidly moving from supporting decisions to making them—playing an increasingly central role in how commerce operates. Their effectiveness depends on the intelligence behind them.

 

 

AI is Becoming the Operating Layer of Global Commerce

 

 

NIQ ensures that the intelligence behind these systems is accurate, complete, and grounded in real-world behavior—reflecting how consumers actually buy, what products are really available, and how markets operate.

 

 

Across the industry, however, the data and measurement required to support this shift remains incomplete. Product data is inconsistent, real-world purchasing behavior is fragmented, availability signals are unreliable, and measurement lacks objectivity. These gaps limit the accuracy, trust, and scalability of AI-driven commerce—and can determine whether products are represented, recommended, or overlooked entirely.

 

 

Building the Intelligence Layer for Agentic Commerce

 

 

The NIQ Commerce Lab will advance a core pillar of NIQ’s AI strategy: Commerce Intelligence.

 

 

Commerce Intelligence is NIQ’s approach to bringing together the full range of signals that shape the market—product, consumer, and retailer data—into a unified system that can understand complex dynamics and power AI-driven decisions that were previously out of reach.

 

 

“NIQ has built the data infrastructure for how commerce actually works,” said Jim Peck, Chairman and CEO of NIQ. “Enabled by AI, we are making a fundamental shift—from measurement and analytics to reading signals in real time and acting on them with confidence. Commerce Intelligence is how we will deliver the intelligence layer the market will depend on, today and in the future.”

 

 

Through the Commerce Lab, NIQ will address six interconnected opportunities required to make Commerce Intelligence real at scale, including:

 

 

• Preference Intelligence — understanding what consumers want
• Product Intelligence — ensuring products are accurately represented
• Availability Intelligence — connecting recommendations to real-world inventory
• Purchase Verification — validating what was actually bought
• Channel Measurement — establishing objective performance and ROI
• Optimization Intelligence — enabling continuous improvement

 

Together, these capabilities are designed to form the intelligence layer that allows AI systems to move from approximation to precision.

 

Why NIQ

 

 

NIQ is uniquely advantaged to build Commerce Intelligence at global scale, combining the data infrastructure, retailer relationships, and neutrality required to fuel AI-driven decisions in commerce.

 

 

• Proprietary Data Infrastructure: NIQ operates data pipelines that ingest point-of-sale transactions from thousands of retailers across nearly every country where commerce happens. This is a technology asset that cannot be recreated by any platform, retailer, or new entrant within the relevant time horizon.
• Structured Product Knowledge at Scale: NIQ’s product catalog represents hundreds of millions of items enriched with billions of structured attributes, generated and maintained by thousands of AI models running continuously. This is the system AI agents need to resolve consumer intent to specific products.
• Closed-Loop Measurement: NIQ links behavior across platforms, channels, and retailers to verified purchase outcomes. This is the measurement infrastructure the category requires to function, and no platform with commercial interests in the transaction can credibly provide it.
• Neutral Advantaged Technology Partner: As an independent party with no retail operation, no advertising platform, and no channel conflict, NIQ is the go-to infrastructure provider participants can trust with the data the market requires.

 

Enabling the Next Phase of Commerce

 

The Commerce Lab will serve to develop the intelligence infrastructure to:

 

 

• Identify emerging commerce signals and dynamics shaping how decisions are made
• Develop new data and measurement capabilities
• Run pilot programs to understand agentic purchasing behavior
• Partner across the AI and commerce ecosystem
• Establish emerging industry standards

 

Leadership

 

NIQ is accelerating its AI agenda with the appointment of Lisa Lovallo Ceppos as Head of AI Commerce. Joining from Google, where she led product strategy for ad effectiveness measurement and Google Maps integration into Vertex AI, Lovallo Ceppos will lead NIQ’s AI commerce product strategy and the continued development of the Commerce Lab—further cementing NIQ’s position at the forefront of Commerce Intelligence.

 

 

To learn more about NIQ’s new Commerce Lab, visit niq.com/agentic-commerce.

 

 

About NIQ

 

 

NielsenIQ (NYSE: NIQ) is a leading consumer intelligence company, delivering the most complete and trusted understanding of consumer buying behavior and revealing new pathways to growth. By combining an unmatched global data footprint and granular consumer and retail measurement with decades of AI modeling expertise, NIQ builds decision systems that help companies turn complex data into confident action.

 

 

With operations in more than 90 countries, NIQ covers approximately 82% of the world’s population and more than $7.4 trillion in global consumer spend. Through cloud-based platforms, advanced analytics and AI-driven insights, NIQ delivers The Full View™—helping brands and retailers understand what consumers buy, why they buy it, and what to do next.

 

 

For more information, please visit www.niq.com.

 

 

Forward-Looking Statements

 

 

This press release contains forward-looking statements. These forward-looking statements address various matters including statements about anticipated timelines, benefits, features, and outcomes of NIQ Commerce Lab and related capabilities and other statements contained in this press release that are not historical facts. These statements are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially. Forward-looking statements speak only as of the date made and NIQ undertakes no obligation to update them except as required by law.

 

 

#NIQ-General

 

 

All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.

 

 

© 2026 Nielsen Consumer LLC. All Rights Reserved.

 

 

FAQ: NIQ Commerce Lab and AI-Driven Commerce

 

 

1. What is the NIQ Commerce Lab?

 

 

The NIQ Commerce Lab is where NIQ discovers, builds, and launches the intelligence infrastructure for AI-driven commerce. It showcases new data assets, measurement methodologies, and partnerships that help the industry better understand and improve how products are discovered, selected, and purchased in AI-powered environments.

 

 

2. What is Commerce Intelligence?

 

 

Commerce Intelligence is NIQ’s new approach to bringing together the full range of signals that shape the market—product, consumer, and retailer data—into a unified system that can understand complex dynamics and power AI-driven decisions that were previously out of reach.

 

 

This includes what the industry often refers to as agentic commerce, but extends across quick commerce, social commerce, and other emerging channels—where AI is becoming the common layer shaping how products are discovered, evaluated, and purchased.

 

 

3. Why is AI-driven commerce different from traditional e-commerce?

 

 

In AI-driven or agentic commerce, AI systems and agents increasingly influence or execute product discovery, selection, and purchasing decisions. This creates new signals as consumers change how they interact with brands and platforms, shifting from search and browsing to automated, intent-driven recommendations and transactions.

 

 

4. What problems is NIQ solving through the Commerce Lab?

 

 

NIQ is advancing a set of interconnected intelligence opportunities that power this shift:

 

 

1. Preference Intelligence — understanding who consumers are and what they want
2. Product Intelligence — ensuring products are accurately represented and discoverable
3. Availability Intelligence — connecting recommendations to real-world inventory and fulfillment
4. Purchase Verification — validating what was actually bought across channels
5. Channel Measurement — establishing objective performance and ROI standards
6. Optimization Intelligence — enabling continuous improvement across the commerce lifecycle

 

Together, these six intelligence opportunities define the data and measurement foundation required for AI-driven commerce to operate reliably and at scale.

 

5. Why does AI-driven commerce require new measurement standards?

 

 

As AI systems begin to influence and execute transactions, traditional digital metrics alone are no longer sufficient. Business decision-makers need objective, third-party measurement to understand performance, validate ROI, and compare results across platforms and channels before shifting meaningful budgets and attention to a new channel. Without this, adoption of AI-driven commerce will be limited.

 

 

6. How does NIQ enable AI-driven commerce?

 

 

NIQ enables AI-driven commerce by providing:

 

 

• Real-world transaction data
• Deep consumer intelligence linked to demographics and behavior
• Rich product data and attributes for accurate matching to user intent
• Independent, third-party measurement and ROI validation

 

These capabilities help ensure AI systems operate with accurate, complete, and trusted information.

 

7. What makes NIQ different from other data or AI providers?

 

 

NIQ is uniquely advantaged to build Commerce Intelligence at global scale, combining the data infrastructure, retailer relationships, and neutrality required to fuel AI-driven decisions in commerce.

 

 

8. What is agentic commerce?

 

 

Agentic commerce refers to AI-driven systems or agents that can discover products, evaluate options, and make or influence purchasing decisions on behalf of consumers or businesses. This represents a shift from manual search and browsing to automated, intent-driven commerce experiences.

 

 

While the industry often refers to this shift as agentic commerce, it is only one way AI may show up. As AI transforms platforms, interfaces, and workflows, NIQ expects that its usage in commerce will go beyond standalone “agents.”

 

 

The more fundamental change is that AI is becoming the system that drives decisions across commerce—regardless of how it is delivered.

 

 

That is why NIQ focuses on Commerce Intelligence: the data, measurement, and context that power these decisions. Whether through agents, assistants, or embedded AI systems, outcomes depend on the quality of the intelligence behind them.

 

 

9. How will AI-driven commerce impact businesses?

 

 

AI-driven commerce is changing the consumer path to purchase in new ways that we don’t fully understand yet. What we do know is that it will change how companies:

 

 

• Reach and influence consumers
• Optimize product discovery and assortment
• Measure performance and ROI
• Allocate marketing and media spend

 

Businesses that adapt to AI-driven decision environments will be better positioned to compete and grow.

 

10. What is NIQ’s role in the future of commerce?

 

 

NIQ is building the Commerce Intelligence layer that powers AI-driven commerce. Through the Commerce Lab and its global data assets, NIQ is helping define how commerce will be measured, optimized, and scaled in an AI-driven world.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260428009576/en/

 

Bhubaneswar, April 23(BNP): Cricket’s fiercest rivalry is set to light up the Mumbai Indians (MI) versus Chennai Super Kings (CSK) encounter at the Wankhede Stadium tonight, but major uncertainty surrounds the availability of two iconic players — MS Dhoni and Rohit Sharma — due to injury concerns.

The IPL 2026 Match 33 is scheduled for 7:30 PM IST, with both teams heading into the contest under contrasting fitness and selection dilemmas ahead of the high-profile “El Clasico” of the tournament.

Fitness Updates

MS Dhoni is reportedly unlikely to feature for CSK due to a calf strain sustained earlier in the season. While he has participated in net sessions, team sources indicate that the veteran wicketkeeper-batter is still not fully match-fit. A final decision will be taken closer to the toss, depending on medical clearance and player readiness.

For CSK, Dhoni’s potential absence continues to be a significant factor, especially given his leadership experience and finishing ability. If he does play, he is expected to be managed carefully, with the Impact Player role being a possible option.

On the Mumbai Indians side, Rohit Sharma is also facing a late fitness test after suffering a hamstring injury earlier this month. He has been seen batting in controlled net sessions, but reports suggest he has avoided high-intensity shots, indicating a cautious recovery approach. His participation will be decided at the toss.

Tactical Considerations

If Rohit Sharma is declared fit but deemed unfit for fielding, Mumbai Indians may deploy him as an Impact Player to maximize his batting contribution while minimizing physical strain. In his absence, MI may continue with alternative opening combinations.

CSK, currently managed by Ruturaj Gaikwad, is closely monitoring Dhoni’s recovery progress. Team management has emphasized that Dhoni will only return when fully cleared by medical staff.

Match Context

The MI vs CSK rivalry remains one of the most iconic matchups in cricket, with MI holding a narrow historical edge in head-to-head records. However, CSK has shown stronger recent form in previous encounters, setting the stage for another tightly contested battle.

With both franchises dealing with leadership pressure, injury uncertainty, and playoff implications, tonight’s clash is expected to be as much about tactical depth and squad balance as individual brilliance.

Final playing XIs for both teams will be confirmed at the toss, with millions of fans awaiting clarity on the participation of two of the IPL’s most influential figures.

Business Wire India

India’s residential landscape is evolving, and so is the demand for reliable, well-designed, and functional home interiors. However, this group also faces various hurdles. For many homeowners, the process of transforming an empty apartment into a dream home remains complex and uncertain. Challenges such as a lack of pricing transparency, unreliable vendors, inconsistent material quality, and difficulty visualising the outcome often make the interior design journey overwhelming.

In response to these industry-wide concerns, NoBroker, a proptech company, launched NoBroker Interiors Services in 2018 to deliver hassle-free interior services with the highest-quality materials at the best prices. In the last 8 years, NoBroker Interiors has opened a total of 5 experience centres in Bangalore, Hyderabad and Pune. These experience centres serve as interactive spaces where customers can explore and plan their homes with confidence.

For the first time ever, homeowners can access a physical, immersive space designed to simplify the home design journey. These NoBroker Interior centres are designed to bridge the gap between conceptual understanding, practical practices, and real-world execution. Unlike traditional interior consultations that rely heavily on digital renders, catalogues, and past work from other homes, NoBroker Interiors Experience Centres offer a more tangible and interactive environment. Homeowners can walk through life-sized layouts of modular kitchens, wardrobes, bedrooms, and living spaces and explore a wide range of materials, finishes such as laminates, membranes, paints, and hardware. This hands-on approach enables customers to assess quality, understand functionality, and make informed decisions with clarity and confidence. More importantly, by interacting with real-time layouts and design elements, homeowners can create, refine, and expand their vision while receiving expert guidance from experienced designers.

Beyond serving as showrooms, the NoBroker Interiors Experience Centres act as consultation hubs where customers can engage directly with professionals to discuss design preferences and project requirements. By combining technology-driven processes with personalised expertise, NoBroker Interiors guarantees its commitment to transparency, efficiency, and customer satisfaction.

In its vision for the future, NoBroker Interiors Experience Centres aims to redefine the interiors industry. As part of its growth strategy, the brand aims to expand its Experience Centres and services to two more Experience Centres in the April to June quarter of 2026 and open five more before the end of the year. This initiative will make professional, accessible interior solutions available to a broader audience. With access to some of the industry’s most experienced designers and a focus on delivering quality-driven outcomes, NoBroker Interior is on the path to redefining how Indians design their homes by providing reliability, expertise, and a seamless interior journey.

As urban housing continues to grow and evolve, initiatives like NoBroker Interiors Experience Centres indicate a shift towards more accessible, transparent, and customer-centric interior design solutions in India. For Bangalore homeowners, particularly those navigating interiors for the first time, these experience centres serve as a valuable starting point.

To know more about the NoBroker Interior Experience Centre, visit them at:

Bangalore:

1. NoBroker Experience Centre HSR: Address: 448, 17th Cross Rd, Sector 4, HSR Layout, Bengaluru, Karnataka 560102
2. NoBroker Experience Centre Horamavu: Address: No 41, HSR Grandeur Horamavu Main Road Chikkahanumantha, Narayana Reddy Layout Rd, Signal, Horamavu, Bengaluru, Karnataka 560113
3. NoBroker Experience Centre Whitefield: 4th floor, Garden of Eden, Survey No 4, Khata 799, Whitefield Main Road, Pattandur Agrahara Village, next to Royal Mart, KR Puram, Whitefield, Bengaluru, Karnataka 560066

Pune:

1. NoBroker Experience Centre Wakad: 305, Bhumkar Nagar, Wakad, Pimpri-Chinchwad, Maharashtra 411057
2. NoBroker Experience Centre Kharadi (Opening in June’26)

Hyderabad:

1. NoBroker Experience Centre Gachhibowli: Kondapur Main Road, opposite Le Meridien, Banjara Basthi, Jayabheri Enclave, Gachibowli, Hyderabad, Telangana 500084

Contact Details for booking enquiry: Phone: +91-804544 2747